Starting Materials
-
RUO and cGMP leukapheresis collections
-
Allogeneic and autologous donor access
-
Diverse, recallable donor registry
-
Full characterization and traceability
Connect with BBG Advanced Therapies in San Diego to explore integrated solutions for starting materials, testing, and biomanufacturing that can accelerate your advanced therapies from concept to clinic.
February 9-12, 2026
San Diego, CA


Gain access to the world’s first Mobile Leukapheresis Center — and see how far our innovations can take you.
Wednesday, February 11, 2026 | 9:15 – 10:15 AM | Theatre 1
Examine emerging decentralized apheresis models and the infrastructure, regulatory considerations, and operational shifts shaping the future of advanced therapies.

Adrienne B. Mendoza, MHA
SVP BioBridge Global and COO,
BBG Advanced Therapies
Wednesday, February 11, 2026 | Time: 10:30-11:15 | Theatre 3
Explore how patient-centric thinking influences advanced therapy design — from donor access and collection models to manufacturing strategies and long-term scalability.

Adrienne B. Mendoza, MHA
SVP BioBridge Global and COO,
BBG Advanced Therapies
We’re driving the BBG Advanced Therapies Mobile Leukapheresis Center straight to San Diego — literally bringing patient access closer to communities and clinical partners as we go. Catch our updates on LinkedIn and track the journey to #ATW2026.

Schedule time with BBG Advanced Therapies to discuss your program goals, challenges, and opportunities—before, during, or after the conference.